Back to search

Article

In silico screening of novel designed series of pyrazolidine compounds targeting Epidermal Growth Factor Receptor

2026-06-19

Abstract excerpt

<title>Abstract</title> <p>Cancer remains a leading cause of global mortality, with epidermal growth factor receptor (EGFR) playing a critical role in tumour progression and drug resistance. Despite the availability of several EGFR inhibitors, their clinical efficacy is often limited by toxicity and the emergence of resistant mutations. In the present study, a novel series of pyrazolidine derivatives was designed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1159794f-da12-5d3f-9afb-1171f7638498
DOI
10.21203/rs.3.rs-9842360/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In silico screening of novel designed series of pyrazolidine compounds targeting Epidermal Growth Factor ReceptorDOI 10.21203/rs.3.rs-9842360/v1
Select a neighboring publication to make it the new centre.